The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
AAV vector-mediated in vivo reprogramming into pluripotency
Open accessAbstract
In vivo reprogramming of somatic cells into induced pluripotent stem cells (iPSC) holds vast potential for basic research and regenerative medicine. However, it remains hampered by a need for vectors to express reprogramming factors (Oct-3/4, Klf4, Sox2, c-Myc; OKSM) in selected organs. Here, we report OKSM delivery vectors based on pseudotyped Adeno-associated virus (AAV). Using the AAV-DJ capsid, we could robustly reprogram mouse embryonic fibroblasts with low vector doses. Swapping to AAV8 permitted to efficiently reprogram somatic cells in adult mice by intravenous vector delivery, evidenced by hepatic or extra-hepatic teratomas and iPSC in the blood. Notably, we accomplished full in vivo reprogramming without c-Myc. Most iPSC generated in vitro or in vivo showed transcriptionally silent, intronic or intergenic vector integration, likely reflecting the increased host genome accessibility during reprogramming. Our approach crucially advances in vivo reprogramming technology, and concurrently facilitates investigations into the mechanisms and consequences of AAV persistence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Fig. 2 In vivo reprogramming in mice using scAAV8 SFFV-hCO-O/K/S/M vectors. a Experimental setup. 38 weeks-old C57BL/6 male mice were injected with 5 × 1010 (n = 9) or 2 × 1011 (n = 9) vg per vector and mouse. 2 and 4 weeks post-injection, three mice per dose and time point were sacrificed, and their organs were extracted and analyzed histopathologically. Remaining mice were sacrificed upon appearance of palpable teratomas (week [w] 7, 8 and 10: 2 × 1011 vg group; month [m] 9: 5 × 1010 vg group). b Hematoxylin/eosin staining of liver teratoma section (mouse treated with 2 × 1011 vg and sacrificed at week 8 post-injection). Structures belonging to the three embryonic germ layers are indicated by black arrows. Scale bar = 100 µm. c iPSC clone derived from a teratoma formed in the liver of the mouse from panel a. Scale bar = 100 µm. The shown clone is representative of 14 IVV-iPSC clones that were derived from mice treated with the OKSM cocktail (four more [IVV-iPSC 15 to 18] were later obtained with OKS, Supplementary Data 1), six of which were from teratomas (see also Fig. 3b). d Hematoxylin/eosin staining of a section of a subcutaneous teratoma generated in mice via injection of clone IVV-iPSC 9. Structures belonging to the three embryonic germ layers are indicated by black arrows. Scale bar = 100 µm. e In vivo reprogramming experiment using a high vector dose (1 × 1012 vg per vector and mouse) injected into 15 weeks-old C57BL/6 male mice (n = 3). Mice were sacrificed upon appearance of palpable teratomas at week 6 post-injection. f Repeat of experiment from panel e, using a scAAV8 vector encoding GFP instead of c-Myc (n = 3). All three mice were sacrificed at month 12 post-injection. One mouse (Supplementary Table 5, mouse #1, assay #6) had a teratoma (yellow arrowhead) in the pancreas. g Histological sections of teratomas (extracted 8 weeks post-injection) from mice injected with a cocktail of scAAV8 vectors encoding hCO-O/K/S/M or TTR promoter-driven Cre recombinase (n = 3). Sections were stained with hematoxylin/eosin and an anti-β-galactosidase (left) or anti-Oct-3/4 antibody (right). Scale bars = 200 µm. This figure contains elements from Servier Medical Art (http://smart.servier.com)](https://figures.cochat.ai/paper-figures/4ae8cbb564e44199bc45e8abf6e82b8c/aav-vector-mediated-in-vivo-reprogramming-into-pluripotency-figure-2.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Continuous expression of all four factors in normal mice, however, often induces teratomas17–19 or is fatal within days16, ostensibly due to tissue dysplasia18.”
From Reprogramming to recover youthful epigenetic information and restore vision (2020) · cites this paper as [19]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Investigators have hitherto shown transduction of specific organs with combinations of OSK or OSKM, but with each encapsulated in a separate vector (Senís et al., 2018)”
From Gene Therapy-Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Related Changes in Aged Mice (2024) · cites this paper as Senís et al., 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Generalized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 4,859
Production of high-titer helper-free retroviruses by transient transfection.
Pear, W. S., Nolan, G. P., Scott, M. L., & Baltimore, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8392 · Cited by 2,266
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K., Davis, C. R., Marion, P., Salazar, F., & Kay, M. A. (2006) · Nature · doi:10.1038/nature04791 · Cited by 1,677
Self-citationCre-dependent selection yields AAV variants for widespread gene transfer to the adult brain
Deverman, B. E., Pravdo, P. L., Simpson, B. P., Kumar, S. R., Chan, K. Y., Banerjee, A., Wu, W.-L., Yang, B., Huber, N., Pasca, S. P., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3440 · Cited by 1,061
In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.
Ocampo, A., Reddy, P., Martinez-Redondo, P., Platero-Luengo, A., Hatanaka, F., Hishida, T., Li, M., Lam, D., Kurita, M., Beyret, E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.052 · Cited by 988
McCarty, D., Monahan, P., & Samulski, R. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301514 · Cited by 735
Grimm, D., Lee, J. S., Wang, L., Desai, T., Akache, B., Storm, T. A., & Kay, M. A. (2008) · Journal of Virology · doi:10.1128/jvi.00254-08 · Cited by 696
Self-citationVisualization of omics data for systems biology
Gehlenborg, N., O'Donoghue, S. I., Baliga, N. S., Goesmann, A., Hibbs, M. A., Kitano, H., Kohlbacher, O., Neuweger, H., Schneider, R., Tenenbaum, D., et al. (2010) · Nature Methods · doi:10.1038/nmeth.1436 · Cited by 620
Cited by
Reprogramming to recover youthful epigenetic information and restore vision
Lu, Y., Brommer, B., Tian, X., Krishnan, A., Meer, M., Wang, C., Vera, D. L., Zeng, Q., Yu, D., Bonkowski, M. S., et al. (2020) · Nature · doi:10.1038/s41586-020-2975-4 · Cited by 820
Sabatino, D. E., Bushman, F. D., Chandler, R. J., Crystal, R. G., Davidson, B. L., Dolmetsch, R., Eggan, K. C., Gao, G., Gil-Farina, I., Kay, M. A., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.06.004 · Cited by 212
Next-generation AAV vectors—Do not judge a virus (only) by its cover
Domenger, C., & Grimm, D. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz148 · Cited by 147
Self-citationProduction, Processing, and Characterization of Synthetic AAV Gene Therapy Vectors
Andari, J. E., & Grimm, D. (2020) · Biotechnology Journal · doi:10.1002/biot.202000025 · Cited by 109
Self-citationMacip, C. C., Hasan, R., Hoznek, V., Kim, J., Metzger, L. E., Sethna, S., & Davidsohn, N. (2023) · doi:10.1101/2023.01.04.522507 · Cited by 95
Metadata
- Authors
- Senís, E., Mosteiro, L., Wilkening, S., Wiedtke, E., Nowrouzi, A., Afzal, S., Fronza, R., Landerer, H., Abad, M., Niopek, D., Schmidt, M., Serrano, M., & Grimm, D.
- Affiliations
- Heidelberg University (DE)
- Spanish National Cancer Research Centre (ES)
- German Cancer Research Center (DE)
- Institució Catalana de Recerca i Estudis Avançats (ES)
- Corresponding author
- Serrano, Manuel
- Grimm, Dirk
- ORCID
- Venue
- Nature Communications
- Published
- 2018-07-09
- Volume
- 9
- Issue
- 1
- Pages
- 2651-2651
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC6037684
- OpenAlex
- W2809896540
- Cited by
- 64
- References
- 81
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 8 · 2023: 8 · 2022: 12 · 2021: 9 · 2020: 8 · 2019: 3 · 2018: 1
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Deutsche Forschungsgemeinschaft (SFB1129-TP2, TRR179-TP18, EXC81)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- in vivo reprogramming, induced pluripotent stem cells, adeno-associated virus vectors, AAV8, mouse embryonic fibroblasts, teratoma, vector integration, genome accessibility
- MeSH terms
- Kruppel-Like Factor 4, Dependovirus, Animals, Cell Line, Cells, Cultured, Embryo, Mammalian, Fibroblasts, Genetic Vectors, Humans, Mice, Inbred C57BL, Mice, Nude, Transcription Factors, Transduction, Genetic, Gene Expression, Sequence Analysis, DNA, Induced Pluripotent Stem Cells, HEK293 Cells, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: AAV vector-mediated in vivo reprogramming into pluripotency. https://app.cochat.ai/papers/10.1038/s41467-018-05059-x
- The paper
- Senís, E., Mosteiro, L., Wilkening, S., Wiedtke, E., Nowrouzi, A., Afzal, S., Fronza, R., Landerer, H., Abad, M., Niopek, D., Schmidt, M., Serrano, M., & Grimm, D. (2018). AAV vector-mediated in vivo reprogramming into pluripotency. Nature Communications. https://doi.org/10.1038/s41467-018-05059-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.